Mini review · 15 Dec 2025
Conference abstractPublished 30 Aug 2021
3D Equivariant Graph Neural Networks for Drug Discovery
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In this talk I will first review a very useful machine learning tool for pharmaceutical applications: the Graph neural Network (GNN). A GNN analyses a signal on graph structured data, such as molecules or knowledge graphs. We then define the concept of equivariance, an organizing principle that embues the neural network with the right transformation properties under symmetry transformations. For instance, a molecule has the same properties whether we rotate it in space or not. We will finally apply the new 3D equivariant graph neural network to molecular data and show that it can successfully predict properties that are relevant for drug screening. If time permits we will briefly describe further relevant generalizations of this technnology.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Research and Pharmacy.
Opinion · 15 Dec 2025
Amr: Global threat, unified one health strategy
Perspective · 15 Dec 2025
Targeted therapies transform cancer & support
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research and Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Max Welling”
